Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Specifically: Adults with a BMI of 30 or higher, or 27+ with a weight-related comorbidity (insulin resistance, hypertension, dyslipidemia) People who've plateaued on semaglutide or tirzepatide and are still short of their metabolic goals Those who are committed to a supervised protocol including labs, dosing adjustments, and dietary support Anyone with a longevity focus who understands that reducing visceral adiposity is one of the highest-leverage metabolic interventions available It is not a fit for people looking for a shortcut without lifestyle engagement
Kurz DJ, Hong Y, Trivier E, Huang HL, Decary S, Zang GH, et al
the PCB-157 BPC-157 is a human gastric juice-derived peptide and exhibits remarkable stability in an acidic environment, unlike most peptides which are degraded at gastric pH
May 17, 2024 - Summer 2024 Provider Check-Up Newsletter is Now Available The Summer edition of the Jefferson Health Plans provider newsletter, Provider Check Up, is now available on our Provider Newsletters page
The practical impact for any individual is determined by your clinician
US$ 20.93
US$ 22.69
US$ 28.69
US$ 26.77
US$ 25.81
